drugset / Trial / NCT00283556
High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the response to treatment and side effects associated with high dose irinotecan in patients with recurrent brain tumors.
Timeline
- Start
- 2001-08
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Irinotecan | Small molecule | 500 mg/m2 | Intravenous |
| Subject | Irinotecan | Small molecule | 600 mg/m2 | Intravenous |
| Subject | Irinotecan | Small molecule | 750 mg/m2 | Intravenous |